BDNF rs6265 Met carriers with alcohol use disorder show greater age-related decline of N-acetylaspartate in left dorsolateral prefrontal cortex.

[1]  B. Nemeș,et al.  BDNF-related mutations in major depressive disorder: a systematic review. , 2022, Acta neuropsychiatrica.

[2]  M. Sacchet,et al.  1H-MRS neurometabolites and associations with neurite microstructures and cognitive functions in amnestic mild cognitive impairment , 2022, NeuroImage: Clinical.

[3]  K. Steece-Collier,et al.  New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism , 2022, International journal of molecular sciences.

[4]  L.-T. K. Tenekedjieva,et al.  Targeting the Salience Network: A Mini-Review on a Novel Neuromodulation Approach for Treating Alcohol Use Disorder , 2022, Frontiers in Psychiatry.

[5]  D. Meyerhoff,et al.  Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies , 2022, Molecular Psychiatry.

[6]  D. Hasin,et al.  Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5. , 2021, Alcoholism, clinical and experimental research.

[7]  Meng Li,et al.  Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts , 2021, Scientific Reports.

[8]  P. Cheah,et al.  Single nucleotide polymorphism of BDNF Val66Met (rs6265) and its association to neuropsychiatric disorders , 2020, Neuroscience Research Notes.

[9]  D. Meyerhoff,et al.  Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders. , 2020, Alcohol and alcoholism.

[10]  K. Humphreys,et al.  Predicting relapse after alcohol use disorder treatment in a high-risk cohort: The roles of anhedonia and smoking. , 2020, Journal of psychiatric research.

[11]  H. Lanfermann,et al.  Altered neurometabolism in major depressive disorder: A whole brain 1H-magnetic resonance spectroscopic imaging study at 3T , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Logan T Dowdle,et al.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development , 2018, Pharmacological Reviews.

[13]  Huaning Wang,et al.  Mechanism of Repetitive Transcranial Magnetic Stimulation for Depression , 2018, General Psychiatry.

[14]  I. Gotlib,et al.  GABA editing with macromolecule suppression using an improved MEGA‐SPECIAL sequence , 2018, Magnetic resonance in medicine.

[15]  K. Hutchison,et al.  Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. , 2014, Alcohol.

[16]  M. Spedding,et al.  Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: How important is BDNF? , 2014, British journal of pharmacology.

[17]  Jens Frahm,et al.  Clinical proton MR spectroscopy in central nervous system disorders. , 2013, Radiology.

[18]  D. Meyerhoff,et al.  Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N‐acetylaspartate levels in the extended brain reward system , 2013, Addiction biology.

[19]  K. Hutchison,et al.  Brain‐derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol‐dependent individuals , 2013, Genes, brain, and behavior.

[20]  K. Hutchison,et al.  Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence , 2012, Front. Pharmacol..

[21]  T. Schneider-Axmann,et al.  Eur Arch Psychiatry Clin Neurosci (2012) 262:23–31 DOI 10.1007/s00406-011-0214-6 ORIGINAL PAPER , 2022 .

[22]  Charles Finsterwald,et al.  Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development , 2011, Communicative & integrative biology.

[23]  Philippe R. Desjardins,et al.  NanoDrop microvolume quantitation of nucleic acids. , 2010, Journal of visualized experiments : JoVE.

[24]  Heather J. Smith,et al.  Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR , 2010, Psychiatric genetics.

[25]  Jürgen Gallinat,et al.  Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex , 2010, NeuroImage.

[26]  J. Callicott,et al.  Impact of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Levels of Hippocampal N-Acetyl-Aspartate Assessed by Magnetic Resonance Spectroscopic Imaging at 3 Tesla , 2008, Biological Psychiatry.

[27]  D. Meyerhoff,et al.  Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence. , 2008, Alcohol and alcoholism.

[28]  Morris H. Baslow,et al.  Using proton magnetic resonance imaging and spectroscopy to understand brain “activation” , 2007, Brain and Language.

[29]  Kevin G Bath,et al.  Variant BDNF (Val66Met) impact on brain structure and function , 2006, Cognitive, affective & behavioral neuroscience.

[30]  Wilson Compton,et al.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2006, The Journal of clinical psychiatry.

[31]  B. Grant,et al.  Comorbidity Between DSM–IV Alcohol and Specific Drug Use Disorders in the United States , 2005, Drug and alcohol dependence.

[32]  Jullie W Pan,et al.  Interdependence of N‐acetyl aspartate and high‐energy phosphates in healthy human brain , 2005, Annals of neurology.

[33]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[34]  S. Gilman,et al.  A longitudinal study of the order of onset of alcohol dependence and major depression. , 2001, Drug and alcohol dependence.

[35]  D. Meyerhoff,et al.  Psychiatric, Demographic, and Brain Morphological Predictors of Relapse After Treatment for an Alcohol Use Disorder , 2017, Alcoholism, clinical and experimental research.